- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04831814
Narrow Band Imaging in Diagnosis of Colorectal Polyps
May 11, 2021 updated by: Nisa Netinatsunton, Prince of Songkla University
Near-focus Versus Normal-focus Narrow Band Imaging Colonoscopy in Diagnosis of Colorectal Polyps Based on Combined NICE and WASP Classification: a Randomized Controlled Trial
Optical diagnosis of colorectal polyps is a promising tool to avoid risks of unnecessary polypectomies and to save costs of tissue pathology.
NICE (NBI International Colorectal Endoscopic) and WASP (Workgroup on Serrated Polyps and Polyposis) classification were developed for diagnosis of adenomatous and sessile serrated polyps, respectively.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Near-focus (NF) narrow-band imaging (NBI) is an image-magnifying technology which enables optical magnification of up to 65x in near focus (NF) compared with 52x in normal standard focus (SF) with the simple push of a button of the endoscope to be interchangeable between NF and SF.
There were few studies comparing diagnostic accuracy between NF and SF in the diagnosis of colorectal polyps.
So, our aim of the current study is to compare accuracy of NF NBI compared with SF NBI in the optical diagnosis of neoplastic and non-neoplastic polyp and the accuracy of NF NBI versus SF NBI in distinguishing serrated adenoma from hyperplastic polyp in sessile lesions using histologic evaluation as the gold standard.
Study Type
Interventional
Enrollment (Actual)
118
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Songkhla
-
Hat Yai, Songkhla, Thailand, 90110
- Prince Songkla University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients who were scheduled for colonoscopy at NKC institute
Exclusion Criteria:
- Inflammatory bowel disease
- Polyposis syndrome
- Colorectal cancer
- Active gastrointestinal bleeding
- Pregnant woman
- Inadequate bowel preparation
- Contraindication for polyps removal
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Near Focus NBI
Use of the Near Focus NBI to make optical diagnosis
|
Colonoscopy with near focus narrowing band imaging technology .
Optical specifications include a 2 mm near field focal depth.
Optical diagnosis of polyps were according to NICE and WASP, respectively.
|
|
Active Comparator: Standard Focus NBI
Use of the Standard Focus NBI to make optical diagnosis
|
Colonoscopy with narrow band imaging technology.Optical diagnosis of polyps were according to NICE and WASP, respectively.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of accurate polyp histology predictions by the Endoscopists in the two groups.
Time Frame: At the time of procedure
|
Measure of the percentage of accurate predictions by the endoscopists in the differentiation of neoplastic from non neoplastic colorectal lesions, using the high definition NBI colonoscopy with and without near focus features
|
At the time of procedure
|
|
Rate of accurate diagnosis of sessile serrated polyps/adenoma by the Endoscopists in the two groups.
Time Frame: At the time of procedure
|
Measure of the percentage od accurate predictions by the endoscopists in the differentiation of sessile serrated polyps/adenoma from hyperplastic polyps, using the high definition NBI colonoscopy with and without near focus features.
|
At the time of procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The polyp detection rate
Time Frame: At the time of procedure
|
The prevalence of patients with at least one polyp was detected
|
At the time of procedure
|
|
The adenoma detection rate
Time Frame: At the time of procedure
|
The prevalence of patients with at least one adenoma was detected
|
At the time of procedure
|
|
Diagnostic Characteristics
Time Frame: At the time of procedure
|
Compare the diagnostic characteristic (sensitivity, specificity, positive predictive value and negative predictive value) using the high definition narrow band imaging colonoscopy with and without near focus features.
|
At the time of procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: NISA NETINATSUNTON, MD., NKC Institute of Gastroenterology and Hepatology, Prince of Songkla University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 4, 2019
Primary Completion (Actual)
July 2, 2020
Study Completion (Actual)
January 14, 2021
Study Registration Dates
First Submitted
April 1, 2021
First Submitted That Met QC Criteria
April 2, 2021
First Posted (Actual)
April 5, 2021
Study Record Updates
Last Update Posted (Actual)
May 12, 2021
Last Update Submitted That Met QC Criteria
May 11, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 61355143
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Neoplasms
-
NuCana plcCompletedColorectal Neoplasms | Colorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, ColorectalUnited States, France, United Kingdom
-
University of ChicagoVerastem, Inc.SuspendedColorectal Cancer | Colorectal Cancer Metastatic | Colorectal Adenocarcinoma | Advanced Colorectal Carcinoma | Advanced Colorectal AdenocarcinomaUnited States
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI); National Institutes of...CompletedColorectal Cancer Metastatic | Colorectal Adenocarcinoma | Stage IV Colorectal Cancer | Stage IVA Colorectal Cancer | Stage IVB Colorectal Cancer | Refractory Colorectal Carcinoma | Metastatic Microsatellite Stable Colorectal Carcinoma | Stage IVC Colorectal CancerUnited States
-
City of Hope Medical CenterRecruitingColorectal Neoplasms | Colorectal Cancer | Colorectal Adenocarcinoma | Colorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Neoplasms Malignant | Colorectal Cancer Stage IUnited States, Japan, Italy, Spain
-
The Queen Elizabeth HospitalNovartis; AmgenCompletedColorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, ColorectalAustralia
-
Novartis PharmaceuticalsCompletedColorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, ColorectalUnited States
-
ProgenaBiomeWithdrawnColorectal Neoplasms | Colorectal Cancer | Colorectal Cancer Metastatic | Colorectal Carcinoma | Colorectal Adenocarcinoma | Colorectal SarcomaUnited States
-
National Cancer Institute (NCI)RecruitingMetastatic Colorectal Adenocarcinoma | Refractory Colorectal Adenocarcinoma | Stage IV Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Unresectable Colorectal AdenocarcinomaUnited States
-
Endeavor HealthEnrolling by invitationColorectal Cancer | Colorectal Adenoma | Colorectal PolypUnited States
-
Bristol-Myers SquibbNovartisCompletedColorectal Cancer | Colorectal Neoplasm | Colorectal Tumors | Colorectal CarcinomaUnited States, Canada, Spain, Argentina, Australia, Belgium, Czechia, Italy, Chile, Germany
Clinical Trials on Near Focus NBI
-
VA Palo Alto Health Care SystemKansas City Veteran Affairs Medical CenterCompletedColonic Polyps | Colorectal NeoplasmUnited States
-
King's College Hospital NHS TrustOlympusCompletedCeliac DiseaseUnited Kingdom
-
Kyunghee University Medical CenterCompleted
-
Jagiellonian UniversitySpecialist Diagnostic and Therapeutic Center MEDICINACompletedNeoplasms | Polyps | Inflammatory Bowel DiseasePoland
-
King Chulalongkorn Memorial HospitalCompletedComplication of Diagnostic Procedure | Adverse Effect of Diagnostic Agents, Subsequent EncounterThailand
-
Michael WallaceOlympus America, Inc.CompletedPost-endoscopic Mucosal Resection of Colon PolypsUnited States
-
Miroslaw SzuraJagiellonian University; Specialist Diagnostic and Therapeutic Center MEDICINAUnknown
-
Portuguese Oncology Institute, CoimbraCompletedColorectal Cancer | Recurrence, Local NeoplasmPortugal
-
Changhai HospitalThe Second Hospital of Hebei Medical University; Air Force Military Medical... and other collaboratorsRecruitingColorectal Sessile Serrated LesionChina
-
Midwest Biomedical Research FoundationMedical University of South Carolina; Academisch Medisch Centrum - Universiteit... and other collaboratorsCompletedGastroesophageal Reflux | Barrett EsophagusUnited States, Netherlands